GeoVax Labs Inc
NASDAQ:GOVX

Watchlist Manager
GeoVax Labs Inc Logo
GeoVax Labs Inc
NASDAQ:GOVX
Watchlist
Price: 0.159 USD -33.78% Market Closed
Market Cap: 4.7m USD

Relative Value

The Relative Value of one GOVX stock under the Base Case scenario is 57.076 USD. Compared to the current market price of 0.159 USD, GeoVax Labs Inc is Undervalued by 100%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

GOVX Relative Value
Base Case
57.076 USD
Undervaluation 100%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
63
vs Industry
66
Median 3Y
2.5
Median 5Y
6.6
Industry
7.8
Forward
1.9
vs History
vs Industry
Median 3Y
-0.6
Median 5Y
-0.8
Industry
24.1
Forward
-0.1
vs History
vs Industry
Median 3Y
-0.6
Median 5Y
-0.8
Industry
21.8
vs History
vs Industry
Median 3Y
-0.6
Median 5Y
-0.8
Industry
23.8
vs History
23
vs Industry
51
Median 3Y
1.5
Median 5Y
1.5
Industry
3.3
vs History
41
vs Industry
74
Median 3Y
-43.9
Median 5Y
1.2
Industry
8
Forward
-0.1
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
10.3
vs History
vs Industry
27
Median 3Y
-0.1
Median 5Y
-0.2
Industry
6.3
Forward
0
vs History
vs Industry
25
Median 3Y
-0.1
Median 5Y
-0.2
Industry
6.7
Forward
0
vs History
vs Industry
29
Median 3Y
-0.1
Median 5Y
-0.3
Industry
7.9
vs History
vs Industry
25
Median 3Y
-0.1
Median 5Y
-0.3
Industry
6.3
vs History
31
vs Industry
20
Median 3Y
3.7
Median 5Y
-1.1
Industry
5.5

Multiples Across Competitors

GOVX Competitors Multiples
GeoVax Labs Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
GeoVax Labs Inc
NASDAQ:GOVX
4.7m USD 1.4 -0.2 0 0
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 873 393.2 -160 995.2 -195 499.5 -193 268.7
US
Abbvie Inc
NYSE:ABBV
400.9B USD 6.7 170.7 16.5 23.4
US
Amgen Inc
NASDAQ:AMGN
176.1B USD 4.9 25.1 18.1 18.1
US
Gilead Sciences Inc
NASDAQ:GILD
154.4B USD 5.3 19 12.8 12.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD 9.9 31.5 23.1 24.2
US
Epizyme Inc
F:EPE
94.1B EUR 2 079.8 -530.7 -577.9 -562.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.9B USD 5.7 17.7 16.8 19.1
AU
CSL Ltd
ASX:CSL
84.8B AUD 3.6 18.7 12.6 15.7
NL
argenx SE
XBRU:ARGX
45B EUR 14.6 34.4 59.4 61
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
52.7B USD 16.4 1 210.8 159.1 192.9
P/E Multiple
Earnings Growth PEG
US
GeoVax Labs Inc
NASDAQ:GOVX
Average P/E: 191
Negative Multiple: -0.2
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 995.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
170.7
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
25.1
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
19
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.5
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -530.7 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.7
9%
2
AU
CSL Ltd
ASX:CSL
18.7
11%
1.7
NL
argenx SE
XBRU:ARGX
34.4
40%
0.9
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 210.8
N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
GeoVax Labs Inc
NASDAQ:GOVX
Average EV/EBITDA: 35.4
0
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 499.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.5
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18.1
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12.8
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.1
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -577.9 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.8
11%
1.5
AU
CSL Ltd
ASX:CSL
12.6
8%
1.6
NL
argenx SE
XBRU:ARGX
59.4
807%
0.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
159.1
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
GeoVax Labs Inc
NASDAQ:GOVX
Average EV/EBIT: 40.8
0
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -193 268.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.4
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18.1
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.8
12%
1.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.2
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -562.5 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.1
13%
1.5
AU
CSL Ltd
ASX:CSL
15.7
11%
1.4
NL
argenx SE
XBRU:ARGX
61
N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
192.9
N/A N/A